RBR-3tvjjkx招募中2 期
Treatment of non-motor symptoms of Parkinson's disease with purified extract of Cannabis sativa
Hospital da Clínicas da Faculdade de Medicina da Universidade de São Paulo0 个研究点开始时间: 2023年1月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 25Y 至 0(—)
入选标准
- •Over 25 years of age; Diagnosis of Parkinson's Disease according to Movement Disorder Society criteria; Present pain related to Parkinson's disease according to the criteria of the Parkinson Disease Pain Classification System Questionnaire; Suffer from chronic pain according to the definition of chronic pain recommended by the 11th edition of the International Classification of Diseases; Able to provide informed consent; Have easy access to a telephone
排除标准
- •Allergy any component of the studied test solutions;Patients using medications with a narrow therapeutic index, and clinically relevant risk due to significant pharmacological interactions with medication studied; Clinically relevant current liver disease, at the discretion of the investigators, and/or hepatitis C; Concomitant use of valproic acid and/or its derivatives;
- •Personal history of schizophrenia and/or bipolar affective disorder; History of psychotic symptoms not justified by Parkinson's Disease; History of suicidal ideation, planning and/or attempt; Research subjects who will not be able to attend to the trial's follow-up assessments; Subjects who do not understand Portuguese; Women of childbearing age, unless they are using an Intrauterine Device or had been previously submitted to tubal ligation; Severe non-compensated psychiatric comorbidities, at the discretion of the researchers; Severe non-compensated clinical comorbidities, at the discretion of the researchers; Pregnant or breastfeeding women; Use in the past 2 years of Cannabis sp. and/or its derivatives for recreational or therapeutic purposes; Personal history of cannabis use disorder and/or other illicit drugs; Personal history of alcohol, tobacco, opioid, benzodiazepine, barbiturate and/or other substance use disorder
研究者
相似试验
招募中
不适用
Clinical observation on the treatment of Parkinson's disease with fatigue by three injectionsParkinson's disease fatigueITMCTR2200006777The First Affiliated Hospital of Guangzhou University of Chinese Medicine
进行中(未招募)
1 期
Investigation of the effect of Nabilon in patients suffering from Parkinson´s Disease with non-motor symptoms (e.g.sleeping disorders,cognitive dysfunction, hallucinations, autonomic dysfunction including urinary incontinence, constipation,...)EUCTR2017-000192-86-ATMedizinische Universität Innsbruck, Universitätsklinik für Neurologie48
进行中(未招募)
1 期
TREATMENT OF DYSKINESIAS IN PARKINSON’S DISEASE WITH OSU6162 – A PILOT STUDYParkinsons disease is complicated by dyskinesias and dystonia. Due stabilizing properties, we believe (-)-OSU6162 may alleviate dyskinesias, without causing parkinsonism. Aim: To evaluate in a double-blind cross over pilot study whether OSU6162 attenuates dyskinesias without worsening parkinsonism in PD patients with motor complications using clinical examination and patient diaries.EUCTR2009-016360-37-SEBjörn Holmberg8
进行中(未招募)
1 期
Investigation of the effect of Nabilon in patients suffering from Parkinson´s Disease with non-Motor symptoms (e.g.sleeping dirsorders, cognitive dysfunction, hallucinations, autonomic dysfunction,...)EUCTR2017-004253-16-ATMedizinische Universität Innsbruck, Universitätsklinik für Neurologie48
招募中
不适用
eurofunctional Physical Therapy in Parkinson's disease: a feasibility trialervous system diseases, Pathological conditions, signs and symptoms, Parkinson's disease.RBR-8n94qgniversidade do Estado de Santa Catarina
